Contemporary Challenges and Innovations in Oncological Diagnosis and Treatment: The Romanian Landscape
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".
Deadline for manuscript submissions: closed (30 June 2024) | Viewed by 3768
Special Issue Editors
2. Institute of Oncology "Prof. Dr. Alexandru Trestioreanu", 022328 Bucharest, Romania
Interests: clinical diagnosis; cancer; chemotherapy; targeted therapy; immunotherapy; radiotherapy
Special Issues, Collections and Topics in MDPI journals
2. Institute of Oncology "Prof. Dr. Alexandru Trestioreanu", 022328 Bucharest, Romania.
Interests: clinical diagnosis; cancer; chemotherapy; targeted therapy; immunotherapy; microbiome
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
It is with great enthusiasm that we unveil a new Special Issue entitled "Contemporary Challenges and Innovations in Oncological Diagnosis and Treatment: The Romanian Landscape". This endeavor is not only a continuation, but also an expansion of work we initiated in our previous successful Special Issue, "Cancer Diagnosis and Oncological Treatments in Romania" (Diagnostics | Special Issue: Cancer Diagnosis and Oncological Treatments in Romania (mdpi.com)), which saw the publication of 15 significant papers, a testament to the dedication of our research community.
The field of oncology remains one of the most dynamic and demanding medical disciplines, with cancer’s impact stretching across the globe and touching lives regardless of borders. In Romania, we confront a unique set of healthcare circumstances shaped by our country's medical history, infrastructure, and the spirit of innovation that Romanian professionals bring to the fore.
After our previous Special Issue’s success, we are inspired to delve deeper into the advancements and confront the challenges that characterize oncological work in Romania. We invite contributions that offer insightful research, critical analysis, and reports on innovative practices that address cancer diagnosis and treatment within our national healthcare ecosystem.
We are seeking submissions that cover a diverse range of topics, including, but not limited to, the following:
- Innovative diagnostic modalities and their efficacy in Romanian clinical settings;
- Progress in molecular targeted therapies and personalized medicine;
- Integration and impact of digital health technologies in oncology;
- Epidemiological studies on cancer trends in the Romanian population;
- Economic evaluations of cancer treatment modalities and their implications for healthcare policy;
- Narratives of collaborative, multidisciplinary treatment approaches;
- Reports from clinical trials examining new treatments for Romanian cancer patients;
- Discussions on the ethical, legal, and social implications of oncological practices in Romania.
Original research articles, comprehensive review articles, insightful case reports, and brief communications are all welcome. Each manuscript should contribute constructively to our understanding of the oncological landscape in Romania, with potential reverberations in the wider international medical community. We invite you to share your latest findings and experiences.
Please make sure to submit your articles through the journal's online system by the deadline, and rest assured that every paper will undergo thorough peer review to ensure it meets the high standards our readers demand.
With warm regards,
Prof. Dr. Dana Lucia Stănculeanu
Dr. Adelina Gheorghe
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- diagnosis
- biopsy
- histopathology
- imaging tests
- biomarkers
- molecular tests
- chemotherapy
- targeted therapy
- immunotherapy
- radiotherapy
- tumor board
- multidisciplinary management
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.